Discovery of thinopyrimidine-triazole conjugates as c-Met targeting and apoptosis inducing agents
2018 · Bioorganic Chemistry · 35 citations
https://doi.org/10.1016/j.bioorg.2018.01.037
X
Xiaobo Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
3.1K
Citations
33
h-index
68
i10-index
Xiaobo Liu is an academic researcher. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Colorectal Cancer Surgical Treatments & Esophageal Cancer Research and Treatment. The author has an h-index of 33, co-authored 147 publications.
ORCID: 0000-0002-8256-6002Papers by this author
worksPredictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma
2012 · Cancer · 30 citations
https://doi.org/10.1002/cncr.27715
Spatiotemporal trends of hemorrhagic fever with renal syndrome (HFRS) in China under climate variation
2024 · Proceedings of the National Academy of Sciences · 29 citations
https://doi.org/10.1073/pnas.2312556121
Synthesis and bioevaluation study of novel N-methylpicolinamide and thienopyrimidine derivatives as selectivity c-Met kinase inhibitors
2017 · Bioorganic & Medicinal Chemistry · 25 citations
https://doi.org/10.1016/j.bmc.2017.11.039
Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort study
2022 · Scientific Reports · 17 citations
https://doi.org/10.1038/s41598-022-13355-2
Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis
2022 · Matrix Biology · 10 citations
https://doi.org/10.1016/j.matbio.2022.06.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat